81qd Revenue and Competitors
Estimated Revenue & Valuation
- 81qd's estimated annual revenue is currently $2.7M per year.
- 81qd's estimated revenue per employee is $101,500
Employee Data
- 81qd has 27 Employees.
- 81qd grew their employee count by 8% last year.
81qd's People
Name | Title | Email/Phone |
---|
81qd Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $22.6M | 142 | -18% | N/A | N/A |
#2 | $41.3M | 259 | 44% | N/A | N/A |
#3 | $808.8M | 3984 | 9% | N/A | N/A |
#4 | $1320M | 1901 | 8% | $445M | N/A |
#5 | $513.8M | 2478 | 11% | $215M | N/A |
#6 | $16.7M | 115 | 4% | N/A | N/A |
#7 | $469.4M | 2264 | 8% | $298.8M | N/A |
#8 | $84.3M | 465 | 33% | N/A | N/A |
#9 | $19.4M | 127 | -2% | $46.6M | N/A |
#10 | $81.2M | 448 | 25% | N/A | N/A |
What Is 81qd?
81qd, an advanced health care data analytics company, provides life sciences organizations with customized, cost-effective solutions designed to maximize their brands' commercial potential through all stages of product development and commercialization. Our name comes from the smallest effective dosage of aspirin for preventing heart attack and stroke-81 mg every day-and it exemplifies our mission of providing high-value, cost-effective solutions. Our multidisciplinary team of data scientists, medical strategists, and marketing professionals has decades of experience in health care analytics. 81qd is differentiated by our ability to provide end-to-end solutions, from strategic planning to tactical execution. We are at the forefront of the latest advances in data science, which power our proprietary solutions to solve our clients' business challenges.
keywords:N/AN/A
Total Funding
27
Number of Employees
$2.7M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.8M | 27 | 0% | $365.3M |
#2 | $4.3M | 27 | -34% | N/A |
#3 | $2.7M | 27 | -53% | N/A |
#4 | $3.9M | 27 | -4% | N/A |
#5 | $1.9M | 27 | -4% | N/A |